ACP
CBIO

Acuta Capital Partners’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History

Acuta Capital Partners’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-275
Closed -$41.3K – 45
2023
Q3 		$41.3K Buy
+275
New +$41.3K 0.03% 41